ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,682Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 223

$644K Total Retail Price of All Prescriptions

Rank: 35 out of 223

609 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 609 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 609 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,781 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 627 609 1 2
SIMVASTATIN 506 475 2 1
AMLODIPINE BESYLATE 465 435 3 6
OMEPRAZOLE 399 374 4 3
FUROSEMIDE 288 273 5 9
HYDROCODONE-ACETAMINOPHEN 275 269 S3 6 5
LISINOPRIL 248 239 7 4
TRAMADOL HCL 233 223 8 18
PAROXETINE HCL 221 219 9 52
METOPROLOL TARTRATE 219 193 10 25
DONEPEZIL HCL 203 203 11 36
WARFARIN SODIUM 202 186 12 11
QUETIAPINE FUMARATE 186 186 13 70
POTASSIUM CHLORIDE 184 183 14 12
GABAPENTIN 180 145 15 10
LABETALOL HCL 157 157 16 154
ALENDRONATE SODIUM 152 122 17 19
ZOLPIDEM TARTRATE 151 149 18 8
GLIPIZIDE ER 144 143 19 98
LANTUS 143 113 20 34
PRAVASTATIN SODIUM 139 121 21 15
ATORVASTATIN CALCIUM 138 123 22 17
METOPROLOL SUCCINATE 130 127 23 20
HYDROCHLOROTHIAZIDE 125 121 24 13
LOSARTAN POTASSIUM 123 121 25 14
KLOR-CON M20 119 114 26 67
NAMENDA 116 116 27 48
ZETIA 114 114 28 68
MIRTAZAPINE 113 113 29 94
METFORMIN HCL 112 96 30 7
BENAZEPRIL HCL 109 107 31 57
METFORMIN HCL ER 107 95 32 41
TAMSULOSIN HCL 101 101 33 26
ALLOPURINOL 95 90 34 28
AZITHROMYCIN 94 85 35 44
DIGOXIN 84 72 36 73
SERTRALINE HCL 79 62 37 21
OXYBUTYNIN CHLORIDE 75 75 38 75
NOVOLOG 72 61 39 97
CLOPIDOGREL 70 61 40 56
ATENOLOL 70 64 40 32
CIPROFLOXACIN HCL 69 68 42 53
DIOVAN 66 66 43 54
POLYETHYLENE GLYCOL 3350 66 66 43 69
OXYBUTYNIN CHLORIDE ER 65 53 45 109
FLUOXETINE HCL 63 58 46 24
TRAZODONE HCL 63 51 46 22
PLAVIX 61 55 48 85
LOSARTAN-HYDROCHLOROTHIAZIDE 58 58 49 31
SEROQUEL 57 57 50 142
AMITRIPTYLINE HCL 57 53 R 50 61
CRESTOR 56 56 52 37
RISPERIDONE 55 46 53 103
JANTOVEN 51 0 54 173
FLUTICASONE PROPIONATE 50 33 55 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.